NEM vs WST · P/E 14, rev $13.43B vs P/E 35, rev $1.72B
Newmont Goldcorp Corp (NEM) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported NEM revenue for 2026-06-30 was $13.43B. Net income was $5.46B. Revenue was up 83.7% from 2026-03-31 to 2026-06-30. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
NEM currently screens at market cap $112.81B and trailing P/E 13.7. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the NEM and WST stock pages for the full models.
Not investment advice.